Current and future prospects for the global biotechnology industry

Journal of Commercial Biotechnology

Volumn 10, Issue 2, 2003, Pages 154-161

  Kermani, Faiz ^a   Bonacossa, Pietro ^b  

^a Chiltern International Ltd   (United Kingdom)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Biotechnology; Clinical trials; Contract research organisations; Drug development; Europe; Japan; Pharmaceutical; R D; Regulatory review; USA

Indexed keywords

ANTIBODY; CYTOKINE; HORMONE; NEW DRUG; PROTEIN DERIVATIVE; VACCINE;

ARTICLE; ASIA; AUSTRALIA; BIOTECHNOLOGY; CANADA; COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; DRUG SYNTHESIS; ECONOMIC EVALUATION; EUROPE; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; NEW ZEALAND; RECOMBINANT DNA TECHNOLOGY; UNITED STATES;

EID: 3042812430     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040069     Document Type: Article

References (16)

1. Sculthorpe, P. and Lowman, D. (2003), 'New Medicine Launches 2002', CMR International (URL: http://www.cmr.org).
2. Drews, J. (1998), 'Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D', Drug Discovery Today, Vol. 3(11), pp. 491-494.
3. Kermani, F. and Findlay, G. (2000), 'The Pharmaceutical R&D Compendium', CMR International (URL:http://www.cmr.org).
4. 'Biotechnology Industry Statistics', Biotechnology Industry Organization (BIO) (URL: http://www.bio.org).
5. Kermani, F. (2000), 'Global Pharmaceutical Pricing: Strategic Issues and Practical Guidelines', Urch Publishing (URL: http://www.urchpublishing.com).
6. Enrst & Young (2002), 'Beyond Borders. The Global Biotechnology Report 2002', Ernst & Young, London.
7. 'Antisoma hails "ground-breaking" Roche cancer deal', PharmaFocus, 18th November 18 (URL: http://www.pharmafocus.com/Pharmafocus/News/story.asp?sID=2684).
8. Anon. (2002), 'Big Pharma offers biotech advice', Scrip, No. 2792, 23rd October, p. 12.
9. 'Biotechnology and Pharmaceutical Markets in the USA' (2003), Trade Partners UK (URL: http://www.tradepartners.gov.uk/biotechnology/usa/profile/overview.shtml
10. 'BIO Applauds House Measure to Correct U.S. Tax Code', 28th July, 2003, Biotechnology Industry Organization (URL: http://www.bio.org/newsroom/newsitem.asp?id=2003_0728_01).
11. 'A stronger framework', December 2002/January 2002, Transpharma 16-19 (URL: http://www.transpharma.biz).
12. 'European Biotech companies held back says report', European Association for Bioindustries (URL: http://www.europabio.org).
13. 'European Innovation Scoreboard', Technical Paper Number 7, 'Biotechnology Innovation Scoreboard', March 2003 (URL: ftp:»ftpnl.cordis.lu/pub/trendchart/reports/documents/report7.pdf).
14. Pilling, D. (2001), 'Pharmaceuticals 2001/Japanese Focus', Financial Times, 26th April.
15. Anon. (2002), 'Japan's Bio and Drug Markets on the Cups of a Golden Era', Biotech Japan (URL: http://www.biojapan.org/industry/r_goldenera.htm).
16. Anon. (2003), 'JETRO events bring together prospective biotechnology partners', Jetro Newsletter, Vol. 13, No. 2 (URL: http://www.jetrocgo.org/data/newsletter/0302.pdf).